ArticleProceedings of the National Academy of Sciences of the United States of America2022

miR-182 targeting reprograms tumor-associated macrophages and limits breast cancer progression.

Chengxin Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.